Beam Therapeutics Inc. Accounts Receivable Change

Accounts Receivable Change of BEAM for past 10 years: annual, quarterly and twelve month trailing (TTM) including Accounts Receivable Change growth rates and interactive chart.


Highlights and Quick Summary

  • Accounts Receivable Change for the quarter ending March 31, 2022 was $300 Million
  • Annual Accounts Receivable Change for 2021 was $-300 Million
Visit stockrow.com/BEAM for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Accounts Receivable Change of Beam Therapeutics Inc.

Most recent Accounts Receivable Changeof BEAM including historical data for past 10 years.

Interactive Chart of Accounts Receivable Change of Beam Therapeutics Inc.

Beam Therapeutics Inc. Accounts Receivable Change for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $300.0
2021 $-300.0

Business Profile of Beam Therapeutics Inc.

Sector: Healthcare
Industry: Biotechnology